Clin2
NCT05935553Possibly a fitRecruiting

Baclofen to help taper benzodiazepines more safely

Benzodiazepine Dependence

Treatments studied

Part of Mental health clinical trials.

This trial tests whether baclofen can make it easier to reduce (taper) benzodiazepines in people who have been dependent for a long time and previously had trouble stopping. If you can safely take part, it may help improve the tapering process and reduce withdrawal problems.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
93 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You have benzodiazepine dependence for more than 12 weeks.
  • In the last 28 days, your average daily benzodiazepine dose was equivalent to 30–200 mg of diazepam.
  • You previously tried a taper but were unable to fully stop at the planned pace.
  • You must be able to give informed written consent and follow study pregnancy rules (if applicable).
  • You must not have certain health or psychiatric conditions (like liver cirrhosis or schizophrenia/bipolar) and must avoid certain interacting medicines.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06757517Recruiting· Phase 2
Nasal spray oxytocin for benzodiazepine withdrawal

This trial tests if a nasal spray containing the hormone oxytocin can help reduce withdrawal symptoms when stopping benzodiazepine (benzos) medications like Valium. You might be eligible if you have been taking a moderate to high daily dose of a benzodiazepine and are entering a hospital program to taper off.

Trondheim, Trøndelag
NCT05765656Recruiting
Doctors and pharmacists helping older adults reduce sleeping pills

This study will see if working closely with your doctor and pharmacist can help older adults safely reduce or stop taking medications for anxiety or sleep, like benzodiazepines.

Nantes
NCT06446349Recruiting
Helping reduce long-term use of benzodiazepine or Z-drugs

This study tests whether a brief motivational interview can help people safely reduce or stop taking benzodiazepines or Z-drugs (like sleeping pills or anxiety meds) they have used daily for at least 6 months. It aims to support patients in trying to lower their dose with their doctor's guidance.

Annonay
NCT07474532Not yet recruiting
Attitudes about stopping sleep or anxiety medicines

This study looks at what older hospital patients think about stopping long-term use of benzodiazepines (medicines for sleep or anxiety). It aims to understand patient beliefs after receiving educational materials about reducing these drugs.

Lyon
NCT06435520Recruiting· Phase 4
Helping people stop sleep medications in primary care

This trial helps people who have been using sleep medications for a long time and want to stop. You will work with your primary care doctor to gradually reduce the medication and learn ways to sleep better without pills.

Denver, Colorado
NCT06467019Recruiting
Reducing benzodiazepine use with educational information

This trial tests if showing educational information to people about reducing or stopping benzodiazepines (a type of sleep or anxiety medication) helps them safely use less. You may be able to join if you're an adult patient at this specific clinic and not already in a similar study.

Vilanova i la Geltrú, Barcelona

Hear when a new Benzodiazepine Dependence trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.